Brain's own opioids may power placebo effect for heartbreak and pain

NCT ID NCT04650841

First seen Jun 25, 2026 · Last updated Jun 27, 2026 · Updated 1 time

Summary

This early-phase study investigates whether the opioid system is involved in placebo effects on both physical pain and the pain of social rejection. Sixty adults who recently experienced an unwanted breakup will receive either naloxone (which blocks opioids) or saline, and be told it is either a pain-reducing spray or a placebo. During brain scans, they will be exposed to heat, pressure, and rejection-related stimuli to measure pain, emotions, and brain activity.

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

Active substance
naloxone nasal spray
What this could lead to
If successful, this could help explain how the brain's natural opioids contribute to placebo effects, potentially guiding future treatments for pain and social distress.
What could go wrong
This is a very early, small study (60 people) focused on understanding mechanisms, not testing a treatment. Results may not apply to broader populations or lead directly to therapies.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for PAIN are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

Pain Rejection, Psychology transplant rejection

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Contacts and locations

Locations

  • Dartmouth College

    Hanover, New Hampshire, 03755, United States

More trials for these conditions

Other studies related to the condition(s) this trial covers.